Relationship between IL-6 and COVID-19: to be considered during treatment
| dc.contributor.author | Vatansever, HS | |
| dc.contributor.author | Becer, E | |
| dc.date.accessioned | 2024-07-18T11:51:17Z | |
| dc.date.available | 2024-07-18T11:51:17Z | |
| dc.description.abstract | The detection and control of pro-inflammatory response is crucial in the early stages of viral infection. Coronavirus disease 2019 (COVID-19) is an emerging viral disease of global concern and optimal treatment has yet to be determined. Unknown response of treatment of COVID-19 is important during patient monitoring. IL-6 is one of the key cytokines after activated macrophages. Therefore, control of systemic IL-6 levels in SARS-CoV-2 infected patients may be a parameter for COVID-19 disease. This review is focused on the induction of IL-6 after viral infections as a target molecule for monitoring cellular response. | |
| dc.identifier.issn | 1746-0794 | |
| dc.identifier.other | 1746-0808 | |
| dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/4761 | |
| dc.language.iso | English | |
| dc.publisher | FUTURE MEDICINE LTD | |
| dc.subject | NF-KAPPA-B | |
| dc.subject | MANAGEMENT | |
| dc.subject | CYTOKINES | |
| dc.subject | CELLS | |
| dc.title | Relationship between IL-6 and COVID-19: to be considered during treatment | |
| dc.type | Article |